NAVF
NEUTRALNAVF notes letter to ASKA Pharma from largest shareholder
The investment fund provides an update on a letter sent by its largest shareholder to the pharmaceutical company.
Nippon Active Value
205.40GBX
0.20%
Market Cap
388.50M
Volume
155.36k
80% of avg
P/E Ratio
EPS (TTM)
N/A
Beta
N/A
Day Range
204.38p - 206.00p
52 Week Range
156.50p205.40p206.98p
205.40p
NAVF
NEUTRALNippon Active Value Fund notes Dalton statement on Fuji Media AGM
The investment fund provides an update on a statement made by one of its advisers regarding a shareholder meeting of a company it holds an investment in.
NAVF
NEUTRALNippon Active Value Fund to Present at Mello London Investor Event
The investment trust will be presenting at an upcoming investor event in London.
NAVF
NEUTRALNippon Active Value Fund Reports 15.2% NAV Total Return for 2024
This investment trust reported a 15.2% NAV total return for 2024, outperforming key indices. Despite strong historical performance, future market volatility and economic uncertainties present challenges.
NAVF
NEUTRALNippon Active Value Fund Responds to Third-Party Committee's Report
The investment trust provides an initial reaction to the release of a third-party committee's investigation report.
NAVF
NEUTRALNippon Active Value Fund celebrates 5th anniversary with 103% NAV gain
The investment trust reports a 103% cumulative NAV gain since launch in 2020, outperforming Japan-focused peers.
NAVF
NEUTRALDirector Buys Shares in Nippon Active Value Fund
A director of this investment management firm has purchased a block of shares, signaling confidence in the business.
NAVF
GOODNippon Active Value Fund Agrees to Trancom Buyout
Nippon Active Value Fund, a specialist investor in undervalued Japanese equities, has agreed to a management buyout of its portfolio company Trancom.
NAVF
GOODNippon Active Value Fund Delivers Strong First-Half Performance
Diversified investment fund delivers impressive returns, supported by robust financials
NAVF
NEUTRALNippon Active Value Fund to Present at Mellow Investment Webinar
Investment trust company to present at industry webinar